Finance

Lists
Why is 300871 up 3.05%?
Dive Deeper
300871:SHE
Wuhan Hvsen Biotechnology Co Ltd
CN¥18.93
+3.05%
(+0.56) 1D
Nov 17, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300871...
Open
CN¥18.12
High
CN¥19.59
Low
CN¥17.72
Mkt. cap
3.71B
Avg. vol.
4.20M
Volume
11.33M
Dividend
2.64%
Quarterly dividend
CN¥0.12
Ex-dividend date
Sep 8, 2026
P/E ratio
12.09
52-wk high
CN¥32.62
52-wk low
CN¥16.34
EPS
CN¥1.57
Shares outstanding
201.78M
No. of employees
1K
Open
CN¥18.12
High
CN¥19.59
Low
CN¥17.72
Mkt. cap
3.71B
Avg. vol.
4.20M
Volume
11.33M
Dividend
2.64%
Quarterly dividend
CN¥0.12
Ex-dividend date
Sep 8, 2026
P/E ratio
12.09
52-wk high
CN¥32.62
52-wk low
CN¥16.34
EPS
CN¥1.57
Shares outstanding
201.78M
No. of employees
1K
News stories
From web sources and news partners
About Wuhan Hvsen Biotechnology Co Ltd
CEO-
Employees1.13K
FoundedJan 25, 2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitewhhsyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
421.71M
458.22M
406.71M
419.78M
Cost of goods sold
272.85M
295.49M
263.77M
292.80M
Cost of revenue
272.85M
295.49M
263.77M
292.80M
Research and development expenses
25.79M
24.40M
29.37M
25.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.04M
40.32M
41.37M
39.37M
Operating expense
86.98M
67.51M
74.25M
48.40M
Total operating expenses
359.83M
363.01M
338.01M
341.20M
Operating income
61.89M
95.21M
68.70M
78.57M
Other non operating income
-354.51K
927.61K
-4.63M
-756.37K
EBT including unusual items
74.07M
87.34M
146.26M
58.62M
EBT excluding unusual items
63.52M
97.69M
61.63M
79.46M
Income tax expense
9.06M
9.10M
18.06M
4.97M
Effective tax rate
12.24%
10.41%
12.35%
8.48%
Other operating expenses
14.44M
711.37K
4.69M
-17.46M
Net income
65.25M
77.67M
128.09M
53.08M
Net profit margin
15.47%
16.95%
31.49%
12.64%
Earnings per share
-
-
-
-
Interest and investment income
4.30M
1.55M
30.40K
856.99K
Interest expense
-1.48M
-
-75.19K
-1.61M
Net interest expenses
2.82M
1.55M
-44.79K
-748.21K
Depreciation and amortization charges
-
-
-
-
EBITDA
91.96M
125.29M
100.14M
108.65M
Gain or loss from assets sale
-
-
-51.32M
51.32M
Upcoming events
AI content may include mistakes. Learn more
Google apps